The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Caryn E. Lerman

Department of Psychiatry

University of Pennsylvania

Philadelphia

Pennsylvania

USA

[email]@*.med.upenn.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 2002 - 2010
  • Department of Psychiatry and Abramson Cancer Center, University of Pennsylvania, 3535 Market Street, Suite 4100, USA. 2002 - 2007
  • University of Pennsylvania, 3535 Market St, Suite 4100, Philadelphia, USA. 2001 - 2005

References

  1. Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Lerman, C., Jepson, C., Wileyto, E.P., Patterson, F., Schnoll, R., Mroziewicz, M., Benowitz, N., Tyndale, R.F. Clin. Pharmacol. Ther. (2010) [Pubmed]
  2. Reinforcing effects of smoking: more than a feeling. Lerman, C., Audrain-McGovern, J. Biol. Psychiatry (2010) [Pubmed]
  3. Translational research in medication development for nicotine dependence. Lerman, C., LeSage, M.G., Perkins, K.A., O'Malley, S.S., Siegel, S.J., Benowitz, N.L., Corrigall, W.A. Nat. Rev. Drug. Discov (2007) [Pubmed]
  4. Genetics and smoking cessation improving outcomes in smokers at risk. Lerman, C.E., Schnoll, R.A., Munafò, M.R. Am. J. Prev. Med (2007) [Pubmed]
  5. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Lerman, C., Jepson, C., Wileyto, E.P., Epstein, L.H., Rukstalis, M., Patterson, F., Kaufmann, V., Restine, S., Hawk, L., Niaura, R., Berrettini, W. Neuropsychopharmacology (2006) [Pubmed]
  6. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Lerman, C., Tyndale, R., Patterson, F., Wileyto, E.P., Shields, P.G., Pinto, A., Benowitz, N. Clin. Pharmacol. Ther. (2006) [Pubmed]
  7. Treating tobacco dependence: state of the science and new directions. Lerman, C., Patterson, F., Berrettini, W. J. Clin. Oncol. (2005) [Pubmed]
  8. Genetic testing for cancer susceptibility: the promise and the pitfalls. Lerman, C., Shields, A.E. Nat. Rev. Cancer (2004) [Pubmed]
  9. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Lerman, C., Wileyto, E.P., Patterson, F., Rukstalis, M., Audrain-McGovern, J., Restine, S., Shields, P.G., Kaufmann, V., Redden, D., Benowitz, N., Berrettini, W.H. Pharmacogenomics J. (2004) [Pubmed]
  10. Changes in food reward following smoking cessation: a pharmacogenetic investigation. Lerman, C., Berrettini, W., Pinto, A., Patterson, F., Crystal-Mansour, S., Wileyto, E.P., Restine, S.L., Leonard, D.G., Shields, P.G., Epstein, L.H. Psychopharmacology (Berl.) (2004) [Pubmed]
  11. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Lerman, C., Niaura, R., Collins, B.N., Wileyto, P., Audrain-McGovern, J., Pinto, A., Hawk, L., Epstein, L.H. Psychol. Addict. Behav (2004) [Pubmed]
  12. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Lerman, C., Berrettini, W. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2003) [Pubmed]
  13. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial. Lerman, C., Shields, P.G., Wileyto, E.P., Audrain, J., Hawk, L.H., Pinto, A., Kucharski, S., Krishnan, S., Niaura, R., Epstein, L.H. Health. Psychol (2003) [Pubmed]
  14. Genetic testing: psychological aspects and implications. Lerman, C., Croyle, R.T., Tercyak, K.P., Hamann, H. J. Consult. Clin. Psychol (2002) [Pubmed]
  15. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., Niaura, R., Epstein, L. Drug. Alcohol. Depend (2002) [Pubmed]
  16. Applying genetic approaches to the treatment of nicotine dependence. Lerman, C., Niaura, R. Oncogene (2002) [Pubmed]
  17. Pharmacogenetic investigation of smoking cessation treatment. Lerman, C., Shields, P.G., Wileyto, E.P., Audrain, J., Pinto, A., Hawk, L., Krishnan, S., Niaura, R., Epstein, L. Pharmacogenetics (2002) [Pubmed]
  18. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Lerman, C., Audrain, J., Tercyak, K., Hawk, L.W., Bush, A., Crystal-Mansour, S., Rose, C., Niaura, R., Epstein, L.H. Nicotine Tob. Res. (2001) [Pubmed]
 
WikiGenes - Universities